Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Tendonitis Treatment Market

Tendonitis Treatment Market Analysis

  • Report ID: GMI8326
  • Published Date: Feb 2024
  • Report Format: PDF

Tendonitis Treatment Market Analysis

Based on treatment, the market is segmented into therapy, surgery, and medications. The therapy segmented is sub segmented into hot & cold therapy, physical therapy, and shockwave therapy. The therapy segment is estimated to account for USD 151.9 billion in 2023.

 

  • Therapy plays a vital role in tendonitis treatment by providing targeted exercises and interventions to strengthen muscles, improve flexibility, alleviate pain, and promote healing, ultimately facilitating patients' recovery and restoring function in affected tendons.

     

  • Furthermore, certain therapies, including hot & cold therapy, shockwave therapy, help to stimulate blood flow and promote tissue repair, facilitating the healing process of injured tendons.

     

  • Moreover, therapies for tendonitis treatment offer significant advantages, including pain relief, promotion of healing, improved range of motion, and cost-effectiveness, contributing to better patient outcomes and satisfaction in the market.

 

Tendonitis Treatment Market, By Application (2023)

Based on application, the tendonitis treatment market is segmented into achilles tendonitis, supraspinatus tendonitis, tennis elbow, pitchers’ elbow, and jumper’s knee. The achilles tendonitis segment is expected reach a market size of USD 142.7 billion by 2032.

 

  • Achilles tendonitis offers significant advantages to patients with effective relief without the need for surgery or invasive procedures.

     

  • Moreover, the devices, such as ankle braces or compression sleeves, protect the tendon during physical activity, preventing further irritation and allowing patients to maintain an active lifestyle while undergoing treatment.

     

  • For instance, in July 2021, Ossur launched Rebound Post-Op Elbow Brace, a non-invasive, lightweight adjustable brace designed to optimize the fitting experience for clinicians and to improve the ease-of-use for patients recovering from severe elbow injury or surgical procedures. This product launch benefited the company by expanding its product portfolio.

     

Based on distribution channel the tendonitis treatment market is classified into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment accounted for a market size of USD of 86.2 billion in the year 2023.

 

  • Hospital pharmacy have access to the latest research and innovations in tendonitis treatment, allowing them to stay at the forefront of evidence-based practice. This enables them to offer patients the most effective and up-to-date treatment options available.

     

  • Additionally, hospital pharmacy is integrated into the healthcare system, allowing for seamless communication and coordination among healthcare providers to optimize patient care in tendonitis treatment. Thus, fostering the segmental growth.

     

Based on end-use the tendonitis treatment market is categorized into hospitals, speciality clinics, home care settings, and other end-users. The hospitals segment accounted for a business share of 44.3% in the forecast period.

 

  • The hospital dominance in market share for tendonitis treatment can be attributed to healthcare capacity to effectively cater patients with various musculoskeletal conditions, including tendonitis, offering specialized care and treatment options tailored to individual needs.

     

  • As per the National Library of Medicine, the success rate for surgical treatment of achilles tendinosis of insertion (TAI) surpasses 80% in most cases.

     

  • Furthermore, the demand for precise tendonitis treatment is heightened in hospitals, especially given the necessity for conducting invasive surgical procedures.

 

North America Tendonitis Treatment Market, 2020 - 2032 (USD Billion)

North America tendonitis treatment market accounted for USD 87 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

 

  • The significant market share is correlated with a sophisticated healthcare infrastructure, an increased prevalence of tendonitis cases, rapid technological advancements, the involvement of sports-related activities, such as high-impact exercises, contributes to the rising incidence of tendonitis.

     

  • The trend of increasing age among the population and a rise in the prevalence of tendon-related injuries contribute to a higher demand for tendonitis treatment options.

     

  • Individuals experiencing tendonitis symptoms, particularly athletes and older adults, seek various treatment modalities, including physical therapy and orthopedic interventions, to alleviate pain and improve mobility, leading to increased demand for tendonitis treatment solutions in the region.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Tendonitis treatment industry reached a revenue of USD 214.6 billion in 2023 and is estimated to cross USD 297.9 billion by 2032 attributed to the rising prevalence of sedentary, lifestyles, continual growth of healthcare expenditure, and the ongoing technological advancements.

The achilles tendonitis application segment is expected to generate USD 142.7 billion in revenue by the end of 2032 as it offers significant advantages to patients with effective relief without the need for surgery or invasive procedures.

North America tendonitis treatment industry size was USD 87 billion in 2023 and is set to expand at a notable CAGR through 2032 owing to the presence of sophisticated healthcare infrastructure, and an increased prevalence of tendonitis cases in the region.

Some of the major tendonitis treatment firms are Abbott Laboratories, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol Myers Squibb Company, Colfax Corporation, GalxoSmithKline AG, Johnson & Johnson, Merck and Co., Inc., Ossur, Pifzer Inc., Stryker Corporation, Teva Pharmaceutical Industries Ltd., Tynor Orthotics Pvt. Ltd, and Zimmer Biomet Holdings, Inc.

Tendonitis Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 394
  • Countries covered: 22
  • Pages: 230
 Download Free Sample